Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02796027 · ClinicalTrials.gov registry record · NA
BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 616
- Enrollment target
NCT02796027 is a NA study that has completed, run by Columbia University. The registered enrollment target is 616 participants.
The verdict
NCT02796027, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 616 participants
- Enrollment target
Study Summary
Scaling up integrated, cost-efficient HIV services for people who inject drugs (PWID) in Needle Syringe Programs (NSPs) is urgently needed in Kazakhstan, where only one-third of the estimated 19,000 HIV-positive PWID are ever linked to HIV care and only 10% initiate ART with 4% achieving viral suppression. The study's aim is to evaluate the implementation, effectiveness, and sustainability of an integrated HIV service model in 24 NSPs located in 3 Kazakhstani city areas. This model will employ highly effective strategies that will include peer-driven recruitment of PWID in NSPs using social network strategies (SNS), integrating rapid HIV testing in NSPs with HIV Care Clinic nurses, and linking HIV positive PWID in NSPs to HIV care using the ARTAS (Anti-Retroviral Treatment and Access to Services) case management model. Findings will have important public health implications for improving HIV service delivery for PWID in the Central Asian region and other countries with injection driven epidemics.
Interventions
- OTHER BRIDGE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 616 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2020-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02796027
The ClinicalTrials.gov registry entry for NCT02796027 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 616 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BRIDGE is the first listed.
NCT02796027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02796027 about?
NCT02796027 is a clinical study titled "BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs". Scaling up integrated, cost-efficient HIV services for people who inject drugs (PWID) in Needle Syringe Programs (NSPs) is urgently needed in Kazakhstan, where only one-third of the estimated 19,000 HIV-positive PWID are ever linked to HIV care and only 10% initiate ART with 4% achieving viral suppr...
What is the current status of trial NCT02796027?
This trial is currently completed. It is a NA study. The enrollment target is 616 participants. The study started on 2017-02-01. Estimated completion is 2020-08-01.
What interventions are being tested in trial NCT02796027?
The interventions under investigation include: BRIDGE (OTHER).
Who is sponsoring clinical trial NCT02796027?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.